Ut wisi enim ad minim veniam, quis laore nostr ud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex

Recent News

  • Port Qasim Electric Power ...

  • With respect to the merger...

  • The Firm was engaged as tr...

© DynamicFrameworks - Mikado ThemeForest Author.


MTC Represents Pfizer in Asset Sale

MTC Represents Pfizer in Asset Sale

Mohsin Tayebaly & Co. was engaged as the sell-side legal advisor on behalf of Pfizer Inc. and Pfizer Pakistan Limited in relation to the sale of:

  1. The manufacturing business of and licenses to market and sell a collection of Pfizer Pakistan Limited / Pfizer Inc. branded product assets; and
  2. The real estate site on which the manufacturing facility is located in SITE, Karachi, and operational assets on a ‘going-concern’ basis.

The Firm’s scope of work as sell-side legal counsel included, without limitation: (i) structuring; (ii) drafting of the transaction documents; (iii) advising on necessary approvals; (iv) providing specific advice on structuring and legal compliance requirements with all appropriate authorities; and (v) negotiating with various potential acquirers.

On May 17, 2024, the relevant Pfizer entities signed Asset Purchase Agreements with Lucky Core Industries Limited (LCI).

The sale of assets to LCI is now set to move ahead, subject to requisite approvals and satisfaction of other conditions.

MTC’s team in this matter was led by Mehreen Manto (Partner) and included Kamil Tayebaly (Associate) and Shanzeh Junnaid (Associate).